The Mobile Toolbox for remote, self-administered cognitive assessment in older adults: associations with in-clinic cognitive testing and Alzheimer's disease biomarkers.

IF 4.4 Q1 CLINICAL NEUROLOGY
Roos J Jutten, Jessa E Burling, Elliott Slade, Jackson C Thompson, Jessie Fanglu Fu, Colin Birkenbihl, Michael J Properzi, Gad A Marshall, Rebecca E Amariglio, Kathryn V Papp, Keith A Johnson, Julie C Price, Reisa A Sperling, Dorene M Rentz
{"title":"The Mobile Toolbox for remote, self-administered cognitive assessment in older adults: associations with in-clinic cognitive testing and Alzheimer's disease biomarkers.","authors":"Roos J Jutten, Jessa E Burling, Elliott Slade, Jackson C Thompson, Jessie Fanglu Fu, Colin Birkenbihl, Michael J Properzi, Gad A Marshall, Rebecca E Amariglio, Kathryn V Papp, Keith A Johnson, Julie C Price, Reisa A Sperling, Dorene M Rentz","doi":"10.1002/dad2.70160","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Remote, smartphone-based cognitive assessments such as the Mobile Toolbox (MTB) may increase the accessibility of Alzheimer's disease (AD) clinical trials. We examined the feasibility of the MTB among cognitively unimpaired (CU) older adults and investigated its associations with standardized in-clinic cognitive testing and amyloid and tau positron emission tomography imaging.</p><p><strong>Methods: </strong>A total of 100 CU older adults self-administered the MTB remotely on their personal devices. Linear regression models correcting for demographics investigated associations of MTB fluid and crystallized cognition composites with in-clinic Preclinical Alzheimer's Cognitive Composite-5 (PACC-5) scores, global amyloid-beta burden and tau deposition in the medial-temporal lobe and neocortex.</p><p><strong>Results: </strong>Most participants completed the MTB without requiring assistance (81%) or reminders (61%). MTB fluid cognition scores were positively associated with PACC-5 scores and negatively with tau deposition in the medial-temporal lobe and neocortex.</p><p><strong>Discussion: </strong>These findings suggest that the MTB may provide a feasible approach to capture cognitive processes relevant in preclinical AD.</p><p><strong>Highlights: </strong>The Mobile Toolbox (MTB) is a remote smartphone-based cognitive assessment.We deployed the MTB in CU older adults with Alzheimer's disease (AD) biomarkers.We show how the MTB may facilitate cognitive assessment in preclinical AD research.</p>","PeriodicalId":53226,"journal":{"name":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","volume":"17 3","pages":"e70160"},"PeriodicalIF":4.4000,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12362792/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/dad2.70160","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Remote, smartphone-based cognitive assessments such as the Mobile Toolbox (MTB) may increase the accessibility of Alzheimer's disease (AD) clinical trials. We examined the feasibility of the MTB among cognitively unimpaired (CU) older adults and investigated its associations with standardized in-clinic cognitive testing and amyloid and tau positron emission tomography imaging.

Methods: A total of 100 CU older adults self-administered the MTB remotely on their personal devices. Linear regression models correcting for demographics investigated associations of MTB fluid and crystallized cognition composites with in-clinic Preclinical Alzheimer's Cognitive Composite-5 (PACC-5) scores, global amyloid-beta burden and tau deposition in the medial-temporal lobe and neocortex.

Results: Most participants completed the MTB without requiring assistance (81%) or reminders (61%). MTB fluid cognition scores were positively associated with PACC-5 scores and negatively with tau deposition in the medial-temporal lobe and neocortex.

Discussion: These findings suggest that the MTB may provide a feasible approach to capture cognitive processes relevant in preclinical AD.

Highlights: The Mobile Toolbox (MTB) is a remote smartphone-based cognitive assessment.We deployed the MTB in CU older adults with Alzheimer's disease (AD) biomarkers.We show how the MTB may facilitate cognitive assessment in preclinical AD research.

Abstract Image

Abstract Image

老年人远程自我管理认知评估的移动工具箱:与临床认知测试和阿尔茨海默病生物标志物的关联
基于智能手机的远程认知评估,如移动工具箱(MTB)可能会增加阿尔茨海默病(AD)临床试验的可及性。我们研究了MTB在认知未受损(CU)老年人中的可行性,并研究了其与标准化临床认知测试和淀粉样蛋白和tau正电子发射断层扫描成像的关系。方法:共有100名CU老年人在个人设备上远程自我管理MTB。校正人口统计学的线性回归模型研究了结核分枝杆菌液体和结晶认知复合物与临床前阿尔茨海默病认知复合物-5 (PACC-5)评分、整体淀粉样蛋白- β负担和中颞叶和新皮层中tau沉积的关系。结果:大多数参与者在没有帮助(81%)或提醒(61%)的情况下完成了MTB。MTB流体认知评分与PACC-5评分呈正相关,与内侧颞叶和新皮层的tau沉积呈负相关。讨论:这些发现表明MTB可能提供了一种可行的方法来捕捉与临床前AD相关的认知过程。亮点:移动工具箱(MTB)是一种基于智能手机的远程认知评估。我们在患有阿尔茨海默病(AD)生物标志物的CU老年人中部署了MTB。我们展示了MTB如何促进临床前阿尔茨海默病研究中的认知评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.80
自引率
7.50%
发文量
101
审稿时长
8 weeks
期刊介绍: Alzheimer''s & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) is an open access, peer-reviewed, journal from the Alzheimer''s Association® that will publish new research that reports the discovery, development and validation of instruments, technologies, algorithms, and innovative processes. Papers will cover a range of topics interested in the early and accurate detection of individuals with memory complaints and/or among asymptomatic individuals at elevated risk for various forms of memory disorders. The expectation for published papers will be to translate fundamental knowledge about the neurobiology of the disease into practical reports that describe both the conceptual and methodological aspects of the submitted scientific inquiry. Published topics will explore the development of biomarkers, surrogate markers, and conceptual/methodological challenges. Publication priority will be given to papers that 1) describe putative surrogate markers that accurately track disease progression, 2) biomarkers that fulfill international regulatory requirements, 3) reports from large, well-characterized population-based cohorts that comprise the heterogeneity and diversity of asymptomatic individuals and 4) algorithmic development that considers multi-marker arrays (e.g., integrated-omics, genetics, biofluids, imaging, etc.) and advanced computational analytics and technologies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信